ArriVent BioPharma Earnings
NASDAQ: AVBPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
10.52-0.74 (-6.57%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
ArriVent BioPharma earnings summary
In its most recent report on Nov 9, 2026 (Sep/2026), AVBP posted EPS of $-0.81 versus the $-1.04 consensus estimate, a positive surprise of 22.1%. Revenue for the quarter was $5.0 million. Across the last 11 reports, AVBP shares moved an average of 5.0% (in either direction) in the first trading session after results, rising 5 times and falling 6 times.
Summary generated from market data by MetaCap's automated system. Methodology
AVBP earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Nov 9, 2026 | $-1.04 | $-0.81 | +22.1% | -19.1% |
| Aug 12, 2026 | — | $-1.05 | — | -1.3% |
| May 11, 2026 | — | $-0.96 | — | -4.1% |
| Mar 5, 2026 | — | $-0.69 | — | +2.0% |
| Nov 10, 2025 | — | $-0.83 | — | -1.6% |
| Aug 11, 2025 | — | $-0.90 | — | +3.0% |
| May 12, 2025 | — | $-1.90 | — | +5.4% |
| Mar 3, 2025 | — | $-0.60 | — | -4.0% |
| Nov 14, 2024 | — | $-0.61 | — | +0.9% |
| Aug 14, 2024 | — | $-0.65 | — | -0.4% |
| May 8, 2024 | — | $-0.70 | — | +13.6% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.